exacerbated by elevated temperature. In summary, these results suggest temperature fluctuations could be a trigger for long-QT and Brugada related arrhythmias.
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Trafficking Defective Mutations Modulate Na V 1.5 N-Glycosylation States Aurelie Mercier, Romain Clement, Patrick Bois, Aurelien Chatelier. Poitiers University, poitiers, France. Voltage gated sodium channels are membrane proteins that play a critical role in electrical signaling of excitable cells. Amongst this family, the isoform Na v 1.5 is responsible for the initiation and propagation of cardiac action potentials. As most of membrane proteins, Na v 1.5 is well known to be a glycoprotein with~5% of its total weight corresponding to carbohydrates. To date, it has been shown that Na v 1.5 glycosylations such as sialylations influence biophysical properties of this channel protein. However, whereas N-glycosylation are well known post-traductional modifications that modulate surface localization of many ionic channels, little is known about these maturation impacts on voltage gated sodium channels. Perturbation of Na v 1.5 trafficking is a well characterized phenomenon occurring in pathology such as Brugada syndrome. Our laboratory previously revealed that trafficking defective mutants of Nav1.5 exert a dominant negative effect upon wild type protein surface localization. The objective of this study was (i) to characterize N-glycosylations of Na v 1.5 during its membrane trafficking and (ii) to investigate these maturations in the context of the dominant negative effect exerted by Na v 1.5 trafficking defective mutations. ] i overload and triggered activity (TA). We hypothesized that I NaL is enhanced in SHR and contribute to APD prolongation and TA. I NaL was increased in ventricular myocytes isolated from 10-to 12-month-old SHR (0.8450.13 pA/pF, n ¼ 16) compared to age-matched Wistar rats (WR; 0.2650.06 pA/pF, n ¼ 9; p < 0.01). I NaL inhibitors ranolazine (RAN) and GS-458967 (GS967) reduced I NaL in myocytes from SHR with IC 50 of 3.750.1 and 0.6550.04 mM; respectively. APD 70 and APD 90 were prolonged in myocytes from SHR, compared to WR, and were shortened by RAN (10 mM) and GS967 (1 mM) (Table) . In 8/23myocytes from SHR, spontaneous delayed afterpotentials (DADs) and/or TA were observed. Pacing induced DADs in 8/10 and TA in 4/10 myocytes from SHR. GS967 (1 mM) abolished both spontaneous and pacing induced TA (4/4).Our data show that I NaL is enhanced and contributes to APD prolongation and TA in myocytes from SHR. Selective inhibition of I NaL could stabilize cardiac repolarization and suppress arrhythmias in hypertension. ]i homeostasis were preserved. We then determined the effect of GS967, a newly developed selective and potent inhibitor of INa,L. Results: (1) During the various phases of AP waveform, the dynamic INa,L amplitude was low at phase-1, gradually increased during phase-2 to reach a peak, and declined at phase-3. This profile of INa,L magnitude and time course under AP-clamp is distinctively different from the monotonically declining INa,L current seen under rectangular pulse voltage-clamp due to non-equilibrium gating. (2) GS967 selectively inhibits INa,L during AP in a concentration-dependent manner with an IC50 of 57 nM. Unlike tetrodotoxin, GS967 did not significantly inhibit the fast Na þ current. Hence, GS967 shortened the AP duration without affecting the AP upstroke. Nociceptive sensory neurons transmit painful stimuli from the periphery to the central nervous system. Voltage-gated sodium (NaV) channels are instrumental for the generation of the corresponding electrical signals, but -so far -the sensory neuron-specific NaV1.9 only appeared to play a minor role. Recently, we identified a de novo heterozygous mutation in the SCN11A gene encoding for NaV1.9 and demonstrated the implication of NaV1.9 in human pain perception (Leipold et al., Nature Genetics, DOI 10.1038 /ng.2767 . Surprisingly, in affected individuals the mutation (L811P) leads to an inability to experience pain by conferring gain-of-function (GOF) properties to NaV1.9. Mutant channels activate at hyperpolarized voltages and display a slow-down of channel inactivation and deactivation, thereby causing sustained depolarization of nociceptor cells and alterations of action potential characteristics. This new channelopathy is different from other pain-related NaV channel disorders: a GOF of homologous NaV1.7 channels is associated with chronic pain, and loss of functional NaV1.7 channels causes congenital indifference to pain. To gain further insight into the mechanisms underlying the mutation we introduced the homologous L-to-P mutation into channel isoforms NaV1.4 (L802P), NaV1.7 (L957P) and NaV1.8 (L890P) and compared the functional parameters of wild-type and mutant channels by means of the whole-cell patch-clamp technique. The L-to-P mutation shifted the activation in all channel subtypes to hyperpolarized potentials in the order NaV1.9 > NaV1.7 > NaV1.4 > NaV1.8. Fast channel inactivation was slowed down most prominently in NaV1.9 and NaV1.8, followed by NaV1.7 and NaV1.4. These results show that a homologous L-to-P mutation affects channel activation and inactivation in a subtypespecific manner.
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Epilepsy Increases the Contribution of Tetrodoxin-Sensitive Channels to the Cardiac Sodium Current Michael Biet 1 , Nathalie Morin 1 , Sandra Duss 2 , Nathalie Sanon 2 , Lionel Carmant 2 , Robert Dumaine 1 . 1 Physiology and Biophysics, University of Sherbrooke, Sherbrooke, QC, Canada, 2 Centre de recherche Ste-Justine, Université de Montréal, Montréal, QC, Canada. Human mortality associated with status epilepticus (SE) in U.S and Canada is 21%-22%. Sudden death caused by epilepsy (SUDEP) accounts for 17% of all SE-related casualties. Clinical evidence linked SUDEP to arrhythmias such as conduction block and prolongation of the QT interval, an index of repolarization time, on the cardiac electrocardiogram. These observations suggest that SE altered the activity of the cardiac sodium current (I Na ) involved in both cardiac conduction and repolarization of the ventricle. We tested this hypothesis by characterizing I Na in ventricular cardiomyocytes of epileptic rats induced induced by kainic acid injection. Our patch clamp results show that epilepsy increased peak I Na by 1856% and its sustained (late) component (I NaL ) by 53513%. Activation of I Na occurred at more negative potential in epileptic rats and recovery from activation was significantly delayed by epilepsy. Because epilepsy is known to increase the expression of neuronal channels (nNaVs) in the brain we next tested if the changes in I Na were associated with increased sensitivity to tetrodotoxin (TTX), a hallmark of nNaVs. Our results indicate that TTX at a concentrations not affecting the cardiac sodium channel NaV1.5 (1 nM) blocked 34% and 50% of I NaL in Sham and epileptic rats respectively. Epilepsy therefore increased the contribution of neuronal sodium channel to I Na in the cardiac ventricle. In summary, our data indicate that epilepsy altered I Na in a manner consistent with the alterations of 328a Monday, February 17, 2014 
